From Bakery and snacks dot com, via the Wall Street Journal's Best of the web
This is worth a search...
...later...
Not much available on-line except for a whole lot of press releases, but this from Bio News is of interest
During pre-clinical studies all three bioactives recorded a significant
decrease in blood sugar levels in diabetic animal models and also recorded a
significant reduction in the level of glycated hemoglobin HbA1c in comparison to
the controls.
The claim is that it slows down the absorbtion of carbs, making high GI foods into low GI foods. Of serious interest to Type 2's if it really works.
Meanwhile, April 4th they announced phase III clincial trials, to see if humans react the same as in their animal trials, and a month later they are doing the product launch... no pressure....
No comments:
Post a Comment